Sunday, 29 April 2007
(When the shoe was on the other foot, Abbott asked for a compulsory license, while criticizing Thailand for issuing compulsory licenses)
On the 12th of January 2007, Abbott Laboratories lost a bid in a U.S. District Court (the Western District of Wisconsin) for a compulsory license on a patent held by Innogenetics, Inc. that a judge and jury said Abbott infringed to manufacture and sell Hepatitis C virus (HCV) genotyping test kits.
Continue Reading →
Cite as Judit Rius Sanjuan, James Love and Robert Weissman, Protection of Pharmaceutical Test Data: A Policy Proposal, KEI Research Paper 2006:1.
PROTECTION OF PHARMACEUTICAL TEST DATA: A POLICY
PROPOSAL*1
Judit Rius Sanjuan, James Love and Robert Weissman*2
KEI Research Paper 2006:1
21 November 2006
Continue Reading →
KEI Research Note 2007:2 [1]
(A PDF version of this is available here.)
Recent examples of the use of compulsory
licenses on patents[1]
KEI Research Note 2007:2
Continue Reading →
$1 a day HIV/AIDS drug regimen
In the early 2000s, KEI’s founder, James Love, advocated to lower the price of HIV/AIDS drugs for patients in developing countries. Love convinced generic manufacturer Cipla to sell the standard 3-drug HIV/AIDS regimen for $1 per day, a breakthrough price that saved — and continues to save — millions of lives. Love’s work culminated in the creation of the Global Fund for HIV/AIDS, TB and Malaria and the President’s Emergency Plan For AIDS Relief (PEPFAR), two of the world’s largest providers of HIV/AIDS treatments.
Continue Reading →
In May 2009, at the WIPO Standing Committee on Copyright and Related Rights (SCCR) 18th session, the governments of Brazil, Ecuador and Paraguay formally tabled a proposal to WIPO endorsing the World Blind Union’s Treaty for Reading Disabled Persons.
Continue Reading →
At KEI Washington, DC offices.
When: Tuesday June 30, 2009
Time: 12:30-2:00pm
Location:
Knowledge Ecology International (KEI)
1621 Connecticut Ave NW, Suite 500
Washington, DC 20009
Tel +1 202 332 2670
Matthew Flynn, a doctoral candidate in Sociology at the University of
Texas at Austin, will be presenting some of his dissertation research on
Brazilian pharmaceutical policies. The topics include Brazil’s use of
compulsory licenses, the Bolar Exception, and production of
anti-retrovirals in public laboratories. Matthew holds a Masters of
Continue Reading →
On May 25, 2009, Brazil, Ecuador and Paraguay (BEP) submitted a formal proposal at the WIPO SCCR 18, asking that the SCCR consider a proposal for a treaty that was presented to the SCCR in 2008 by the World Blind Union. In 2010, the government of Mexico joined as a co-sponsor of the treaty proposal.
Below is the text of the BEP submission at WIPO:
WIPO STANDING COMMITTEE ON COPYRIGHT AND RELATED RIGHTS
Eighteenth Session Geneva, May 25 to 29, 2009
Continue Reading →
The Obama Administration, with the support of a Democrat-controlled U.S. Congress, is insisting the Anti-Counterfeiting Trade Agreement (ACTA) negotiations be conducted in secret. We know, from documents obtained in Europe and the summaries released in April 2009, that the draft ACTA has sections that deal with both injunctions and damages. We don’t have the current text. Continue Reading →
*The author thanks Professor Marc Perlman (Brown University) for his comprehensive notes on the IGC deliberations.
Continue Reading →
TACD has issued a resolution on copyright terms, and measures to mitigate the harm from excessive terms. The TACD Press release follows:
Continue Reading →